Linda D. Ferrell, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Linda D. Ferrell, MD

Professor, Department of Pathology, UCSF

Phone: (415) 353-1090 (appts)
Box 0102, UCSF
San Francisco, CA 94143-0102

View on UCSF Profiles

Education

University of Kansas, Lawrence KS, B.A., 1974, Microbiology
University of Kansas, Lawrence KS, M.D., 1977, Medicine
University of Kansas, Lawrence KS, Resident, 1977-79, Pathology
Univ. California, San Francisco, CA, Chief Resident, 1980-81, Pathology


Professional Experience

  • 1988-94
    Associate Professor of Pathology and Surgery, University of California, San Francisco, CA
  • 1994-present
    Professor of Pathology, University of California, San Francisco, CA
  • 1999-present
    Vice Chair of Clinical Affairs, Director of Surgical Pathology

Honors & Awards

  • 1983
    Academic Senate Distinguished Teaching Award, UCSF
  • 1984
    American Roentgen Ray Executive Council Award
  • 1987
    Kaiser Award for Excellence in Teaching, UCSF
  • 1987
    Distinction in Teaching, Pathology Residents
  • 1989
    125th Anniversary Celebration Award for Exceptional Contribution, UCSF
  • 1991
    "Major Contribution to Teaching" award, 1993 Medical Student Class, UCSF
  • 1992
    MS IV Award for Teaching Excellence, UCSF
  • 1993
    MS IV Award for Teaching Excellence, UCSF
  • 1993
    Recognition Award, US and Canadian Academy of Pathology
  • 1994
    MS IV Award for Teaching Excellence, UCSF
  • 1994
    MS IV Award for Teaching Excellence, UCSF

Selected Publications

  1. Hepatocellular Carcinoma Arising in an HNF-1a-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report. Semin Liver Dis. 2015 Nov; 35(4):444-9.
    View on PubMed
  2. Immunohistochemical pitfalls in the diagnosis of hepatocellular adenomas and focal nodular hyperplasia: accurate understanding of diverse staining patterns is essential for diagnosis and risk assessment. Mod Pathol. 2015 Jan; 28(1):159-60.
    View on PubMed
  3. Well-differentiated hepatocellular neoplasm of uncertain malignant potential. Hum Pathol. 2015 Apr; 46(4):634-5.
    View on PubMed
  4. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis. Hum Pathol. 2015 Mar; 46(3):426-33.
    View on PubMed
  5. Monoclonal light chain deposits within the stomach manifesting as immunotactoid gastropathy. Ultrastruct Pathol. 2015 Feb; 39(1):62-8.
    View on PubMed
  6. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. Mod Pathol. 2014 Nov; 27(11):1499-509.
    View on PubMed
  7. Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease. Am J Surg Pathol. 2014 Feb; 38(2):205-14.
    View on PubMed
  8. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Hum Pathol. 2014 May; 45(5):976-83.
    View on PubMed
  9. Different collagen types show distinct rates of increase from early to late stages of hepatitis C-related liver fibrosis. Hum Pathol. 2014 Jan; 45(1):160-5.
    View on PubMed
  10. Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category--reply. Hum Pathol. 2014 Mar; 45(3):660-1.
    View on PubMed
  11. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol. 2014 Jan; 27(1):62-72.
    View on PubMed
  12. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013; 2013:268625.
    View on PubMed
  13. Hepatic steatosis estimated microscopically versus digital image analysis. Liver Int. 2013 Jul; 33(6):926-35.
    View on PubMed
  14. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res. 2013 Jan; 6(1):3-9.
    View on PubMed
  15. Atypical hepatocellular adenoma-like neoplasms with ß-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. Hum Pathol. 2013 May; 44(5):750-8.
    View on PubMed
  16. Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade. Radiology. 2012 Jul; 264(1):88-96.
    View on PubMed
  17. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View on PubMed
  18. Ethnicity and nonalcoholic fatty liver disease. Hepatology. 2012 Mar; 55(3):769-80.
    View on PubMed
  19. Solitary rectal ulcer syndrome in children and adolescents. J Pediatr Gastroenterol Nutr. 2012 Feb; 54(2):266-70.
    View on PubMed
  20. Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol. 2012 Jan; 137(1):5-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI